Stanley Laman Group Ltd. lowered its holdings in shares of Monsanto (NYSE:MON) by 36.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,889 shares of the basic materials company’s stock after selling 6,327 shares during the period. Stanley Laman Group Ltd.’s holdings in Monsanto were worth $1,272,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of MON. Intl Fcstone Inc. acquired a new stake in Monsanto during the second quarter worth $794,000. PSquared Asset Management AG lifted its holdings in shares of Monsanto by 6.1% during the third quarter. PSquared Asset Management AG now owns 1,352,651 shares of the basic materials company’s stock valued at $162,075,000 after acquiring an additional 78,331 shares during the period. Oakbrook Investments LLC lifted its holdings in shares of Monsanto by 7.4% during the third quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock valued at $2,438,000 after acquiring an additional 1,400 shares during the period. Honkamp Krueger Financial Services Inc. lifted its holdings in shares of Monsanto by 73.6% during the third quarter. Honkamp Krueger Financial Services Inc. now owns 4,608 shares of the basic materials company’s stock valued at $552,000 after acquiring an additional 1,954 shares during the period. Finally, APG Asset Management N.V. lifted its holdings in shares of Monsanto by 9.8% during the third quarter. APG Asset Management N.V. now owns 706,078 shares of the basic materials company’s stock valued at $84,602,000 after acquiring an additional 63,100 shares during the period. Hedge funds and other institutional investors own 73.70% of the company’s stock.
Shares of Monsanto (MON) opened at $121.10 on Tuesday. The firm has a market capitalization of $53,240.00, a PE ratio of 22.33, a price-to-earnings-growth ratio of 1.73 and a beta of 1.01. Monsanto has a twelve month low of $109.61 and a twelve month high of $123.15. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05.
Monsanto (NYSE:MON) last posted its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). The company had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. Monsanto’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.21 earnings per share. equities analysts anticipate that Monsanto will post 5.76 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.78%. Monsanto’s payout ratio is currently 39.93%.
In other news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the transaction, the executive vice president now directly owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.70% of the stock is currently owned by insiders.
A number of research analysts have issued reports on the company. Wells Fargo & Co reissued a “market perform” rating and set a $128.00 price objective (up from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $127.30.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.